Alamar Biosciences, Inc.
28.96USD
-0.9900 (-3.31%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.2▲ | $-0.21 | 2 | 0 |
| Next quarter | $-0.2▼ | $-0.18 | 1 | 2 |
| Current year | $-1.16▲ | $-1.46 | 4 | 0 |
| Next year | $-0.54▲ | $-0.7 | 1 | 2 |
Beat in 1 of the last 1
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.32 | $-0.2 | +0.12 (+37.4%) |
6 ratings from 4 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Stifel | Maintained | Buy | $28 $32 | Aug 11, 2026 |
| JP Morgan | Maintained | Overweight | $32 $35 | Aug 11, 2026 |
| Leerink Partners | Initiated | Outperform | $35 | May 12, 2026 |
| TD Cowen | Initiated | Buy | $30 | May 12, 2026 |
| JP Morgan | Initiated | Overweight | $30 | May 12, 2026 |
| Stifel | Initiated | Buy | $28 | May 12, 2026 |
11 filings from 7 insiders · 0 buy / 0 sell over 6m
Officers and directors of ALMR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| RAGUSA ROBERT PDirector | GrantStock Option (Right to Buy) | 25.6k | — | — | Sep 1, 2026 |
| RAGUSA ROBERT PDirector | Grant | 5.7k | — | — | Sep 1, 2026 |
| NACLERIO NICHOLAS J.Director | Grant | 5.7k | — | — | Apr 20, 2026 |
| NACLERIO NICHOLAS J.Director | Buyindirect | 235.3k | $22.00 | $5.18M | Apr 20, 2026 |
| NACLERIO NICHOLAS J.Director | Otherindirect | 617.8k | — | — | Apr 20, 2026 |
| MCANEAR JUSTIN JChief Financial Officer | Grant | 37.2k | — | — | Apr 20, 2026 |
| ILLUMINA INNOVATION FUND II GP, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 235.3k | $22.00 | $5.18M | Apr 20, 2026 |
| ILLUMINA INNOVATION FUND II GP, L.L.C.Beneficial Owner of more than 10% of a Class of Security | Otherindirect | 617.8k | — | — | Apr 20, 2026 |
| LUO YULING PH.D.Chief Executive Officer | Grant | 76.5k | — | — | Apr 20, 2026 |
| CHEN SHIPING PH.D.Chief Operating Officer | Grant | 37.2k | — | — | Apr 20, 2026 |
| WHITE TIMOTHYPresident | Grant | 37.2k | — | — | Apr 20, 2026 |
No analyst notes on ALMR yet.
Analyst Ratings
5 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 3 | 1 | 0 | 0 | Buy2.00 |
| 1 mo ago | 1 | 3 | 1 | 0 | 0 | Buy2.00 |
| 2 mo ago | 1 | 3 | 1 | 0 | 0 | Buy2.00 |
| 3 mo ago | 1 | 3 | 1 | 0 | 0 | Buy2.00 |